Follow
Dan Rossignol
Dan Rossignol
Rossignol Medical Center
Verified email at rossignolmedicalcenter.com - Homepage
Title
Cited by
Cited by
Year
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
DA Rossignol, RE Frye
Molecular psychiatry 17 (3), 290-314, 2012
8892012
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and …
DA Rossignol, RE Frye
Molecular psychiatry 17 (4), 389-401, 2012
6352012
Melatonin in autism spectrum disorders: a systematic review and meta‐analysis
DA Rossignol, RE Frye
Developmental Medicine & Child Neurology 53 (9), 783-792, 2011
5442011
Environmental toxicants and autism spectrum disorders: a systematic review
DA Rossignol, SJ Genuis, RE Frye
Translational psychiatry 4 (2), e360-e360, 2014
5162014
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism
DA Rossignol, RE Frye
Frontiers in physiology 5, 76429, 2014
3552014
Cerebral folate receptor autoantibodies in autism spectrum disorder
RE Frye, JM Sequeira, EV Quadros, SJ James, DA Rossignol
Molecular psychiatry 18 (3), 369-381, 2013
2872013
Novel and emerging treatments for autism spectrum disorders: a systematic review
DA Rossignol
Ann Clin Psychiatry 21 (4), 213-236, 2009
2652009
Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders
RE Frye, DA Rossignol
Pediatric research 69 (8), 41-47, 2011
2512011
Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder
S Rose, DM Niyazov, DA Rossignol, M Goldenthal, SG Kahler, RE Frye
Molecular diagnosis & therapy 22, 571-593, 2018
1902018
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
DA Rossignol, LW Rossignol, SJ James, S Melnyk, E Mumper
BMC pediatrics 7, 1-13, 2007
1702007
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
DA Rossignol, LW Rossignol, S Smith, C Schneider, S Logerquist, ...
BMC pediatrics 9, 1-15, 2009
1582009
Emerging biomarkers in autism spectrum disorder: a systematic review
RE Frye, S Vassall, G Kaur, C Lewis, M Karim, D Rossignol
Annals of translational medicine 7 (23), 2019
1352019
Evidence of mitochondrial dysfunction in autism and implications for treatment
DA Rossignol, JJ Bradstreet
American Journal of Biochemistry and Biotechnology 4 (2), 208-217, 2008
1322008
A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel
RE Frye, D Rossignol, MF Casanova, V Martin, G Brown, SM Edelson, ...
Frontiers in public health 1, 53879, 2013
1202013
Hyperbaric oxygen therapy may improve symptoms in autistic children
DA Rossignol, LW Rossignol
Medical hypotheses 67 (2), 216-228, 2006
1072006
Melatonin in autism spectrum disorders
DA Rossignol, RE Frye
Current clinical pharmacology 9 (4), 326-334, 2014
1052014
Identification and treatment of pathophysiological comorbidities of autism spectrum disorder to achieve optimal outcomes
RE Frye, DA Rossignol
Clinical Medicine Insights: Pediatrics 10, CMPed. S38337, 2016
1022016
Treatments for biomedical abnormalities associated with autism spectrum disorder
RE Frye, DA Rossignol
Frontiers in pediatrics 2, 66, 2014
902014
Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder
JJ Bradstreet, S Smith, M Baral, DA Rossignol
Altern Med Rev 15 (1), 15-32, 2010
892010
Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism
DA Rossignol
Medical Hypotheses 68 (6), 1208-1227, 2007
892007
The system can't perform the operation now. Try again later.
Articles 1–20